SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
SGTX
Delisted
SGTX was delisted on the 10th of August, 2023.
33 hedge funds and large institutions have $8.5M invested in Sigilon Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
33
Holding in Top 10
–
Calls
$7K
Puts
–
Top Buyers
| 1 | +$27.7K | |
| 2 | +$24.9K | |
| 3 | +$8K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.31K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$564 |
Top Sellers
| 1 | -$39.3K | |
| 2 | -$39K | |
| 3 | -$36.4K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$16.5K |
| 5 |
Morgan Stanley
New York
|
-$6.44K |